[[{“value”:”
Cannabis Europa London 2025, Europe’s premier forum connecting the visionaries, policymakers, and business leaders shaping the cannabis industry, is now less than two weeks away.
As Europe’s cannabis market enters a new chapter of growth, with rapid advances in medical cannabis, progressive regulatory shifts and ongoing battles to liberalise cannabis taking place across the continent, our sponsors remain at the core of its evolution.
We are proud to be supported by some of the cannabis industry’s most forward-thinking and influential businesses. Their backing helps create an environment where innovation thrives, meaningful connections are made, and bold ideas can take shape.
Join us in London on June 25-26 alongside more than 1,500 influential leaders, to get to know these industry architects, pioneers and torchbearers face-to-face. Below is just a small selection of the many industry-leading companies supporting Cannabis Europa 2025.
PHCANN International – Headline Sponsor
Cannabis Europa 2025’s Headline Sponsor is PHCANN International, a leading multinational pharmaceutical cannabis company, underscoring its devotion to driving innovation, regulatory progress, and sustainable growth within the sector.
With a strong presence across Europe, PHCANN International continues to lead the way in the production and distribution of pharmaceutical-grade cannabis products, ensuring compliance with the highest industry standards. Their commitment to research, innovation, and patient access aligns perfectly with the objectives of Cannabis Europa.
“Being Headline Sponsor of Cannabis Europa this year is a natural extension of our goal to drive meaningful conversations and foster strategic partnerships that will advance patient access and industry standards. We look forward to engaging with thought leaders, policymakers, and industry pioneers as we collectively accelerate the development of a sustainable and responsible cannabis market in Europe,” said Sasho Stefanoski, CEO of PHCANN International.
Mr Stefanoski will take to the main stage on the second day of the conference to discuss the evolution and future of EU-GMP requirements for global operators, and whether pharmaceutical standards are truly needed for cultivation.
Vladimir Kofcegarski, Chief Sales Officer at PHCANN International, continued: “Our mission is to advance access to high-quality, pharmaceutical-grade cannabis products across Europe, while collaborating with regulators, healthcare professionals, and industry stakeholders. This event provides a vital opportunity for us to do that.”
The Entourage Effect – Silver Sponsor
This year’s conference will see more delegates from the thriving Oceanic cannabis markets of Australia and New Zealand than ever before.
One such company making its way to the Barbican later this month will be The Entourage Effect, one of Australia’s leading wholesalers of medicinal cannabis products.
Its founder, Eidan Havas, originally trained in criminal law, but like many of the industry’s most passionate voices was introduced to medical cannabis through personal, first hand experience of its therapeutic potential.
Since its founding in 2022, The Entourage Effect has grown quickly, expanding to multiple wholesale and distribution centres across the country. MiDispensary, based in New South Wales, is one of the state’s first specialist cannabis clinics, offering tailored cannabis treatments alongside MiPharmacy, which dispenses personalised medications directly to patients.
Mr Havas will join a panel on the second day of the conference to share insights from the Australian market on how Europe can achieve breakthroughs in patient access to reach 500,000 patients.
“The European cannabis sector is rapidly evolving, driven by progressive regulatory changes and increasing investment in medical and wellness markets,” Mr Havas said.
“Key players are focusing on high-quality, research-backed products and building robust supply chains to meet growing patient and consumer demand across diverse markets.”
The VOR Group – Silver Sponsor
Established just last year, the VOR Group are wasting no time in introducing themselves to Europe’s cannabis community.
The VOR Group is a UK-based health and wellness company specialising in advanced cannabis product development, distribution, and sales. The company develops innovative cannabis formulations targeting pain, cancer, mental health, and general well-being.
Through its distribution operations, The VOR Group imports and supplies international cannabis brands to pharmacies and major UK retailers. In the medical market, it imports and sells prescription cannabis products, building strategic global partnerships.
The company also owns and represents a portfolio of wellness brands, with retail placements secured in major outlets including Holland & Barrett and Superdrug.
Linnea – Silver Sponsor
With over 40 years experience Linnea’s extensive expertise sets the company apart and guarantees quality and innovation.
Since 1982 Linnea has been committed to high quality botanical API manufacturing in our GMP certified facility in Ticino Switzerland.
With a focus on sustainability and the environment, Linnea is a leading pharmaceutical manufacturer producing both botanical extracts & isolates and semi-synthetic APIs derived from botanicals
Avicanna – Silver Sponsor
Avicanna is an international biopharmaceutical company dedicated to the medical and pharmaceutical applications of cannabinoids. Under the leadership of founder and CEO Aras Azadian, the company has built a reputation for scientific innovation and clinical excellence, with a robust pipeline of proprietary cannabinoid-based products.
Since 2016, Mr Azadian and the Avicanna team have navigated the complexities of global cannabis regulation, driving forward research, clinical development, and commercialisation across multiple international markets, always with a focus on evidence-based, data-driven innovation.
“As the sector evolves and markets gradually liberalise, a clear separation between adult-use and medical cannabis companies, their ethos and their focus, remains essential. The next phase of progress must not neglect patients or the vital role of the medical community,” Mr Azadian said.
He’ll join panellists on the main stage on Wednesday to dive into these topics in more detail, discussing the essential role of evidence-based products, clinician education, and integrated support programmes in earning the trust of both patients and the medical community.
Cantourage UK – Silver Sponsor
Cantourage UK, part of the Berlin-based European medical cannabis powerhouse of the same namesake, is out in force at this year’s event, with all three of its co-founders in attendance.
Niall Ivers, Chief Operating Officer & Co-Founder, Gabriel Newman, Co-Founder & CEO, and Joshua Cuby, Co-Founder & Chief Sales Officer are collectively shortlisted for ‘Business Leader of the Year’ at this year’s Business of Cannabis Awards, taking place on the first evening of the event.
Our independent panel of judges have also shortlisted Cantourage UK for ‘Cannabis Team of the Year’ and ‘Cannabis Clinic of the Year’, in what is set to be a memorable night for all.
Mr Ivers, said: “The European cannabis sector is at a pivotal moment, the opportunity is massive, but long-term success depends on creating a positive feedback loop for all stakeholders, especially regulators. If they have a good experience, the whole industry thrives, and that’s how we build a profitable, sustainable future.
His colleague, Mr Newman, will be exploring this topic and what place medical cannabis has in the thriving wellness sector in the Greenhouse on the first day of the event.
Elsewhere, Mr Cuby will take part in a panel discussion on the main stage on the same day, delving into the role the UK is set to play in ‘Europe’s Green Frontier’.
He commented: The… sector holds immense untapped potential, with data-driven insights and patient-reported outcomes poised to unlock the true therapeutic value of this natural medicine. Yet progress remains hindered by fragmented regulation, limited public awareness, and cautious investment, keeping us far from realising its full promise.”
Grow Group – Silver Sponsor
Grow Group is a patient-first medical cannabis company, dedicated to improving quality of life for those who can benefit from cannabinoid-based therapies.
Its passionate team, which span clinical, scientific and commercial expertise, is led by CEO Pierre Van Weperen, who brings more than 30 years of experience in the pharmaceutical industry, and a personal commitment to driving patient outcomes.
Since joining GROW in 2019, he has led the company’s efforts to educate healthcare professionals, support regulatory progress, and deliver innovative products and services to patients and prescribers.
He’ll be heading up the first panel of the conference, taking a much wider view of the issues currently facing the UK’s healthcare sector, with millions waiting for diagnosis and treatment of conditions such as chronic pain, endometriosis, ADHD, and PTSD, and how medical cannabis could offer an alternative solution.
Paralab – Bronze Sponsor
Paralab is a leading manufacturer and supplier of advanced cannabis post-harvest and extraction technology, serving Europe, Israel, and Latin America.
Founded by CEO Rui Soares, Paralab brings over 30 years of expertise in highly regulated pharmaceutical markets to the cannabis sector, offering a full suite of EU-GMP compliant solutions across every stage of the cannabis value chain ,from bioburden control to extraction, purification, and packaging.
An ISO 9001:2015 certified company with an EU-GMP certified laboratory and an R&D license for cannabis products, Paralab helps producers achieve precision, consistency, and flexibility in an increasingly competitive and diverse cannabis market.
Mr Soares will join a panel of experts on day two of the conference to discuss the future of the cannabis industry, and the emerging technologies likely to shape it, from small-batch and craft production methods that cater to premium markets, to advanced extraction innovations like microwave-assisted and ultrasound-assisted extraction that improve both efficiency and product quality.
Curaleaf Laboratories – Bronze Sponsor
Curaleaf Laboratories is the UK’s largest medical cannabis processing facility and a trusted manufacturing and distribution partner for cannabis companies entering or expanding in the UK market.
Part of the Curaleaf International group since 2019, Curaleaf Laboratories evolved from Rokshaw, a well-established specials medicines manufacturer with over a decade of expertise in unlicensed medicines. Today, it serves as a one-stop shop for UK cannabis brands — offering flexible, EU-GMP-compliant manufacturing, quality control, and scalable distribution across the country.
Curaleaf Laboratories works with a wide range of domestic and international partners, providing packaging, labelling, and compliance expertise that helps brands navigate the UK’s evolving regulatory landscape. The company’s adaptable approach, including low minimum order quantities and broad market access through all UK clinics and pharmacies, enables partners to manage risk while responding to real market demand.
At its core, Curaleaf Laboratories is committed to helping the UK medical cannabis sector thrive through collaboration, quality, and patient-focused innovation. We’re excited to welcome them as a sponsor at Cannabis Europa 2025, where they continue to champion a rising tide philosophy for the entire industry.
“}]] We are proud to be supported by some of the cannabis industry’s most forward-thinking and influential businesses. Their backing helps create an environment where innovation thrives, meaningful connections are made, and bold ideas can take shape. Read More
